|  Help  |  About  |  Contact Us

Search our database by keyword

- or -

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 1 to 4 out of 4 for Lpl

Category restricted to ProteinDomain (x)

0.015s

Categories

Category: ProteinDomain
Type Details Score
Protein Domain
Type: Family
Description: Lipoprotein lipase (LPL) is a key enzyme of lipid metabolism that hydrolysestriglycerides, providing free fatty acids for cells and affecting the maturation of circulating lipoproteins []. The enzyme is thought to playa role in the development of obesity and atherosclerosis []. Human LPLcontains 448 amino acids; sequence comparison indicates that human LPL,hepatic lipase, and pancreatic lipase are members of a gene family []. Defects in LPL are a cause of familial chylomicronemia syndrome (or type Ihyperlipoproteinemia) and also of a form of deficiency characterised byhypertriglyceridemia. Familial chylomicronemia is a recessive disorderusually manifesting in childhood. On a normal diet, patients often presentwith abdominal pain, hepatosplenomegaly, lipemia retinalis, eruptivexanthomata, and massive hypertriglyceridemia, sometimes complicated withacute pancreatitis.LPL and pancreatic lipase share ~30% sequence identity, suggesting a similartertiary fold []. Molecular models of LPL have been constructed, based on X-ray crystal structures of pancreatic lipase []. These models allowed theauthors to propose hypotheses on the structural determinants of LPL that areresponsible for heparin binding, dimer formation, and phospholipase activity.
Protein Domain
Type: Homologous_superfamily
Description: This domain superfamily is found in apolipoprotein CII (apoC-II). ApoC-II is a surface constituent of plasma lipoproteins and the activator for lipoprotein lipase (LPL). It is therefore central for lipid transport in blood. Lipoprotein lipase is a key enzyme in the regulation of triglyceride levels in human serum []. It is the C-terminal helix of apoCII that is responsible for the activation of LPL []. The active peptide of apoC-II occurs at residues 44-79 and has been shown to reverse the symptoms of genetic apoC-II deficiency in a human subject [].Micellar SDS, a commonly used mimetic of the lipoprotein surface, inhibits the aggregation of apoC-II and induces a stable structure containing approximately 60% α-helix. The first 12 residues of apoC-II are structurally heterogeneous but the rest of the protein forms a predominantly helical structure [].
Protein Domain
Type: Family
Description: Apolipoprotein CII (apoC-II) is a surface constituent of plasma lipoproteins and the activator for lipoprotein lipase (LPL). It is therefore central for lipid transport in blood. Lipoprotein lipase is a key enzyme in the regulation of triglyceride levels in human serum []. It is the C-terminal helix of apoC-II that is responsible for the activation of LPL []. The active peptide of apoC-II occurs at residues 44-79 and has been shown to reverse the symptoms of genetic apoC-II deficiency in a human subject [].Micellar SDS, a commonly used mimetic of the lipoprotein surface, inhibits the aggregation of apoC-II and induces a stable structure containing approximately 60% α-helix. The first 12 residues of apoC-II are structurally heterogeneous but the rest of the protein forms a predominantly helical structure [].
Protein Domain
Type: Homologous_superfamily
Description: This superfamily represents the fold comprising the seven β-strands found in the catalytic domain of Class II of aminoacyl-tRNA synthetases (aaRS), the lipoyl protein ligase (LPL) and the biotinyl protein ligase (BPL). Interestingly, Class II of aaRSs has a two-step reaction mechanism analogous to that of BPL. It first catalyses the ATP-dependent formation of an aminoacyl-AMP intermediate and then transfer the activated aminoacyl moiety to an acceptor tRNA [].The aminoacyl-tRNA synthetases (also known as aminoacyl-tRNA ligases) catalyse the attachment of an amino acid to its cognate transfer RNA molecule in a highly specific two-step reaction [, ]. These proteins differ widely in size and oligomeric state, and have limited sequence homology []. The 20 aminoacyl-tRNA synthetases are divided into two classes, I and II. Class I aminoacyl-tRNA synthetases contain a characteristic Rossman fold catalytic domain and are mostly monomeric []. Class II aminoacyl-tRNA synthetases share an antiparallel β-sheet fold flanked by α-helices [], and are mostly dimeric or multimeric, containing at least three conserved regions [, , ]. However, tRNA binding involves an α-helical structure that is conserved between class I and class II synthetases. In reactions catalysed by the class I aminoacyl-tRNA synthetases, the aminoacyl group is coupled to the 2'-hydroxyl of the tRNA, while, in class II reactions, the 3'-hydroxyl site is preferred. The synthetases specific for arginine, cysteine, glutamic acid, glutamine, isoleucine, leucine, methionine, tyrosine, tryptophan, valine, and some lysine synthetases (non-eukaryotic group) belong to class I synthetases. The synthetases specific for alanine, asparagine, aspartic acid, glycine, histidine, phenylalanine, proline, serine, threonine, and some lysine synthetases (non-archaeal group), belong to class-II synthetases. Based on their mode of binding to the tRNA acceptor stem, both classes of tRNA synthetases have been subdivided into three subclasses, designated 1a, 1b, 1c and 2a, 2b, 2c [].BPLs and LPLs are evolutionarily related protein families, with a homologous catalytic module (seven-stranded mixed β-sheet on one side and four α-helices on the other side) that must have evolved from a common ancestor [, ]. Amino acid sequence conservation between the catalytic modules of biotinyl protein ligases (BPLs) and lipoyl protein ligases (LPLs) is very low, and mainly affects residues that are important for the scaffold of the structure, such as those contributing to the hydrophobic core. Despite the poor overall sequence similarity, a single lysine residue is strictly conserved in all LPL and BPL sequences. This lysine residue is likely to bind specifically to the carbonyl oxygen of the carboxyl group of biotin or at the end of the hydrogen-carbon tail of the lipoyl moiety [].